GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Guangzhou Jet Bio-Filtration Co 688026.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

23.08

+3.17%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥565.4m

FY2016FY2025

Net income

CN¥48.2m

FY2016FY2025

Free cash flow

CN¥67.7m

FY2016FY2025

Shareholders' equity

CN¥1.22bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥565.4mCN¥558.7mCN¥463.1mCN¥609.8mCN¥855.7mCN¥503.9mCN¥247.5mCN¥207.5mCN¥167.0mCN¥124.0m
Research and developmentCN¥29.1mCN¥26.3mCN¥28.5mCN¥37.3mCN¥43.8mCN¥23.9mCN¥12.6mCN¥8.6mCN¥7.9mCN¥7.6m
Operating incomeCN¥61.3mCN¥95.7mCN¥39.4mCN¥101.0mCN¥210.9mCN¥148.2mCN¥76.4mCN¥61.2mCN¥43.5mCN¥24.5m
Net incomeCN¥48.2mCN¥72.2mCN¥34.8mCN¥87.7mCN¥171.2mCN¥119.4mCN¥66.2mCN¥52.8mCN¥40.4mCN¥26.1m
Diluted earnings per share0.350.520.260.621.211.120.730.710.950.61

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥1.74bnCN¥1.70bnCN¥1.63bnCN¥1.61bnCN¥1.18bnCN¥969.7mCN¥397.4mCN¥328.2mCN¥229.8mCN¥201.5m
Cash and short-term investments—CN¥459.2mCN¥539.1mCN¥598.9mCN¥263.5mCN¥356.5mCN¥76.1mCN¥32.4mCN¥19.3mCN¥19.9m
Total liabilitiesCN¥516.2mCN¥505.0mCN¥468.5mCN¥465.2mCN¥208.6mCN¥172.8mCN¥49.3mCN¥46.3mCN¥44.0mCN¥55.9m
DebtCN¥382.5mCN¥360.3mCN¥340.2mCN¥321.9mCN¥47.2mCN¥12.3m———CN¥21.0m
Shareholders' equityCN¥1.22bnCN¥1.19bnCN¥1.16bnCN¥1.14bnCN¥971.8mCN¥796.9mCN¥348.1mCN¥282.0mCN¥185.9mCN¥145.6m
Shares outstanding137m139m132m140m141m106m90m74m43m43m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥191.8mCN¥54.0mCN¥134.8mCN¥166.2mCN¥221.4mCN¥187.6mCN¥61.0mCN¥45.1mCN¥46.7mCN¥33.4m
Capital spending−CN¥124.0m−CN¥110.7m−CN¥183.7m−CN¥173.2m−CN¥278.9m−CN¥250.9m−CN¥55.2m−CN¥26.5m−CN¥12.5m−CN¥9.8m
Free cash flowCN¥67.7m−CN¥56.7m−CN¥48.9m−CN¥7.0m−CN¥57.5m−CN¥63.3mCN¥5.8mCN¥18.6mCN¥34.2mCN¥23.6m
Dividends paid−CN¥14.4m−CN¥12.3m−CN¥11.3m−CN¥60.0m−CN¥12.3m−CN¥50.0m—−CN¥12.5m−CN¥870,363−CN¥1.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥169.6mCN¥107.9mCN¥167.2mCN¥130.0mCN¥144.3mCN¥123.8mCN¥167.8mCN¥154.6m
Operating incomeCN¥40.4mCN¥6.8m−CN¥4.6mCN¥19.5mCN¥32.5mCN¥20.8mCN¥34.8mCN¥16.2m
Net incomeCN¥25.0m−CN¥4.2m−CN¥9.1mCN¥11.0mCN¥29.9mCN¥16.5mCN¥22.0mCN¥20.2m
Diluted earnings per share0.18-0.03-0.070.080.220.120.160.15
Cash from operations———CN¥46.0mCN¥38.0mCN¥45.0mCN¥44.0m−CN¥6.0m
Capital spending−CN¥11.0m−CN¥11.0m−CN¥48.0m−CN¥2.0m−CN¥39.0m−CN¥33.0m−CN¥68.0m−CN¥10.0m
Free cash flow———CN¥44.0m−CN¥1.0mCN¥12.0m−CN¥24.0m−CN¥16.0m
Total assetsCN¥1.73bnCN¥1.72bnCN¥1.74bnCN¥1.75bnCN¥1.73bnCN¥1.70bnCN¥1.70bnCN¥1.63bn
Cash and short-term investments———CN¥488.2mCN¥458.9mCN¥457.5mCN¥459.2mCN¥467.1m
DebtCN¥393.7mCN¥388.1mCN¥382.5mCN¥2.3mCN¥371.1mCN¥369.9mCN¥359.9mCN¥355.8m
Shareholders' equityCN¥1.20bnCN¥1.19bnCN¥1.22bnCN¥1.24bnCN¥1.23bnCN¥1.21bnCN¥1.19bnCN¥1.17bn

Financial ratios

Data as of 26 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin10.8%19.6%8.5%18.5%23.0%29.3%
Net margin8.5%12.9%7.5%14.4%20.0%23.7%
Return on equity4.0%6.1%3.0%7.7%17.6%15.0%
Return on assets2.8%4.2%2.1%5.5%14.5%12.3%
Free cash flow yield9.9%5.1%10.3%10.4%15.2%17.7%
Revenue growth1.2%20.6%-24.1%-28.7%69.8%103.6%
Earnings growth-33.2%107.5%-60.3%-48.8%43.4%80.4%
Current ratio7.52x6.68x7.46x7.02x3.95x4.37x
Debt to equity0.31x0.30x0.29x0.28x0.04x0.00x
Equity ratio69.8%69.9%71.2%71.0%82.3%82.2%
Interest coverage2.17x4.11x1.58x8.67x154.20x2068.35x
R&D as a share of sales5.2%4.7%6.2%6.1%5.1%4.7%
Buybacks as a share of market value1.4%-4.9%5.7%0.7%-32.9%-17.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-2.5%2.3%18.6%
Operating income-15.3%-16.2%16.7%
Net income-18.1%-16.6%13.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin14.0%13.5%18.5%19.9%
Net margin10.7%11.1%15.0%16.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings45.524.765.638.552.030.4
Price to sales3.93.24.95.510.47.2

Dividends and splits

Per share, in the currency the company pays

Paid for 6 years. Last went ex-dividend on 31 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year0.0740.0730.0720.0710.600.0860.357
  • 7-for-5 split · 8 Jun 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.